ProShare Advisors’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,223
| Closed | -$26K | – | 2090 |
|
|
2025
Q1 | $26K | Sell |
16,223
-4,060
| -20% | -$6.5K | ﹤0.01% | 2016 |
|
|
2024
Q4 | $73K | Buy |
20,283
+9,204
| +83% | +$33.1K | ﹤0.01% | 2125 |
|
|
2024
Q3 | $63.2K | Buy |
+11,079
| New | +$63.2K | ﹤0.01% | 1950 |
|
|
2022
Q2 | – | Sell |
-12,296
| Closed | -$299K | – | 1835 |
|
|
2022
Q1 | $299K | Sell |
12,296
-2,989
| -20% | -$72.7K | ﹤0.01% | 1631 |
|
|
2021
Q4 | $492K | Buy |
15,285
+10,334
| +209% | +$333K | ﹤0.01% | 1456 |
|
|
2021
Q3 | $221K | Sell |
4,951
-3,983
| -45% | -$178K | ﹤0.01% | 1741 |
|
|
2021
Q2 | $338K | Buy |
+8,934
| New | +$338K | ﹤0.01% | 1812 |
|